InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (3 ops.)
Browse the detailed record of transactions filed by Walker Paul Edward, Director. Director active across 6 companies, notably Monte Rosa Therapeutics, Inc.. Cumulatively, 12 reports have been published. Total volume traded: €5m. The latest transaction was filed on 24 May 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
€361,3305,931,843 shares@ €0.0609100.0% of flow
Common Stock
SEC:0001209191-22-032331:0·
€5m2,631,578 shares@ €1.74670.23% mcap100.0% of flow
Common Stock
SEC:0001209191-22-024322:0·
Ideal exit: 6 Jan 2023 (T+270)
€43,94637,570 shares@ €1.1697100.0% of flow
Common Stock
SEC:0001209191-21-071274·
€43,94637,570 shares@ €1.169750.0% of flow
Common Stock
SEC:0001209191-21-071274:0·
05,736,363 shares0
Common Shares
SEC:0001209191-21-065762·
05,736,363 shares0
Common Shares
SEC:0001209191-21-065762:0·
1,851,852 shares
Common Stock
SEC:0001209191-21-061098·
Ideal exit: 15 Jul 2022 (T+270)
1,851,852 shares
Common Stock
SEC:0001209191-21-061098:0·
Ideal exit: 15 Jul 2022 (T+270)
2,715,968 shares
Common Stock
SEC:0001209191-21-044050·
5,864,718 shares
Common Stock
SEC:0001209191-21-044200·
5,864,718 shares
Common Stock
SEC:0001209191-21-044200:0·
2,715,968 shares
Common Stock
SEC:0001209191-21-044050:0·
12 of 12 declarations
About Walker Paul Edward
Walker Paul Edward is a Board Member of Monte Rosa Therapeutics, Inc., Bright Health Group Inc., and Trevi Therapeutics, Inc. With experience in the healthcare and biotechnology sectors, he contributes to the governance and development strategy of the companies. Paul is recognized for his expertise in innovation and research, which is essential for the growth of the companies.
